Perrigo
This article was originally published in The Tan Sheet
Executive Summary
Private-label manufacturer appoints Mark Olesnavage, presently exec VP and chief operating officer for the firm's OTC business, to the new title of president-OTC pharmaceutical operations, effective Feb. 1. Olesnavage previously served as exec VP-sales and marketing and as VP-pharmaceutical business development. In the latter position, he is credited with developing Perrigo's Rx- to-OTC operations, which led to the marketing of private-label miconazole cream and loperamide